Delivery Order SPE2DX22D0010-SPE2D824FEZ31
- Not listed
- This federal contract award, valued at $50,604.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- This federal contract award, valued at $17,543.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract is for the delivery of 4,567,103,808 units of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. This contract does not...
- This federal contract award, valued at $1,337.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566545113 VYVANSE 40 MG CAPSULE 100S, a prescription medication, with a completion date of November 26, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $47,468.84, was issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of October 6, 2023. The contract provides for the delivery of VYVANSE CAPS 60MG, a pharmaceutical product, to support federal healthcare programs. This award is part of a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,617.00, is for the delivery of VYVANSE CAPS 40MG, a prescription medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,053.70 Firm Fixed Price Delivery Order is for the supply of VYVANSE CAPS 70MG, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $2,704.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a prescription medication, with an ultimate completion date of October 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,892.12, is for the delivery of VYVANSE CAPS 30MG, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,783.36 firm fixed-price delivery order is for the supply of 4566343823 - VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds an Indefinite Delivery Contract...
- This federal contract award, valued at $7,499.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to support military...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FEZ31Delivery Order
This federal contract award, valued at $26,962.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4563141702 VYVANSE CAPS 40MG, a specialty pharmaceutical product, with a completion date of December 20, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.0k | 12/19/23 |